Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company offering non-invasive, rapid testing solutions, today announced the addition of Pyrotek Pty Ltd (“Pyrotek”), to its customer base. Pyrotek is a global leader in engineering solutions. By adopting INBS’ Intelligent Fingerprinting Drug Testing […]

Biora Therapeutics to Reveal 00-Size BioJet(TM) Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that Adi Mohanty, CEO of Biora Therapeutics, will present on the company’s 00-size BioJet(TM) device at the 14th Annual Partnership Opportunities in Drug Delivery (PODD) meeting, taking place in Boston, October 28-29, 2024. “As

Boundless Bio Announces Departure of Chief Financial Officer

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) — Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Jami Rubin has stepped down from her role as Chief Financial Officer (CFO) for personal reasons. Boundless Bio does

ConnectWise and Pax8 Announce Strategic Partnership to Fortify Cybersecurity and Data Protection Solutions for the MSP Ecosystem

TAMPA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) — ConnectWise, the leading software company dedicated to the success of Managed Service Providers (MSPs), and Pax8, the leading cloud commerce marketplace, are excited to announce a strategic partnership to offer ConnectWise’s Managed Detection and Response (MDR)(TM) solution within the Pax8 Marketplace. ConnectWise’s recent acquisition of two leading

Discover the GRAB (GrabWay) Listing on XT Exchange

SINGAPORE, Oct. 14, 2024 (GLOBE NEWSWIRE) — We are excited to announce that GrabWay (GRAB) will soon be listed on XT Exchange, with the GRAB/USDT trading pair available in the Innovation Zone (DEPIN). Please take note of the following go-live schedule: Deposit: October 20, 2024, at 08:00 (UTC) Trading: October 15, 2024, at 08:00 (UTC)

Asset Entities Signs Macy Gray, Multi-Platinum, Grammy Award Winning Artist, to Design, Develop, and Manage Her Music and Entertainment Discord Community

DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) — Asset Entities Inc. (“Asset Entities” or “the Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary Payment Platform company, today announced that renowned Grammy Award-winning R&B and soul singer, songwriter, producer and actress Macy Gray

Kratos Receives $45 Million Satellite System Related Contract Award

SAN DIEGO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security and global markets, announced today that it has recently received a new, sole source, approximate $45 million single award contract related to a new satellite system. Work under this new

Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision Strike Systems at AUSA 2024

SAN JUAN, Puerto Rico, Oct. 14, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc.â?¯(Nasdaq: RCAT) (“Red Cat”), a drone technology company building hardware and software for military, federal, and commercial operations, today introduced its ARACHNID(TM) family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems. Red Cat unveiled the Family of Systems at

Helio Genomics’ Methylation Model Score for Assessing Prognosis and Treatment Response in Patients with Hepatocellular Carcinoma Presented as Top Abstract at the 2024 San Antonio Liver Cancer Symposium

IRVINE, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, showcased the results from their latest collaboration with Ochsner Health, demonstrating the utility of cell-free DNA (cfDNA) methylation-based biomarkers for assessing biological aggressiveness and prognosis in patients

The American Journal of Managed Care(R) and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) — Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care(R) (AJMC) to co-host a symposium focused on value-based cancer care. The event will take place on October 24, 2024, in Miami, Florida, as part of AJMC’s Institute

Scroll to Top